Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 58

Results For "General"

847 News Found

Intuitive launches My Intuitive App
Digitisation | April 11, 2022

Intuitive launches My Intuitive App

The app serves as a single, integrated, personalized customer platform for da Vinci surgeons


Ministry of Ayush to organise two-day convention on World Homeopathy day
News | April 09, 2022

Ministry of Ayush to organise two-day convention on World Homeopathy day

World Homoeopathy Day is observed to commemorate the birth anniversary of the founder of Homoeopathy, Dr. Christian Fredrich Samuel Hahnemann to mark his 267th birth anniversary


Study reveals over 80 % newly diagnosed diabetic patients have at least one cholesterol abnormality
News | April 08, 2022

Study reveals over 80 % newly diagnosed diabetic patients have at least one cholesterol abnormality

The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted


Cadila Pharma launches world’s first three-dose rabies vaccine
News | April 08, 2022

Cadila Pharma launches world’s first three-dose rabies vaccine

The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.


All India Institute of Ayurveda signs MoU with Safdarjung hospital
News | April 07, 2022

All India Institute of Ayurveda signs MoU with Safdarjung hospital

The MoU sets down the guidelines for the establishment of an integrative medicine unit, joint research and academic activities in various fields of interest in Ayurveda and modern medicine


Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
Drug Approval | April 06, 2022

Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19

Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19


MilliporeSigma acquires MAST platform from Lonza
Biotech | April 06, 2022

MilliporeSigma acquires MAST platform from Lonza

MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)


IDMA’s two-day Diamond Jubilee celebrations in Mumbai on April 14-15
News | April 05, 2022

IDMA’s two-day Diamond Jubilee celebrations in Mumbai on April 14-15

The two-day event will showcase achievements and address issues pertaining to the industry


Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board
News | April 04, 2022

Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board

Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Dr. Rohini Anand